Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) EBT (2022 - 2025)

ASP Isotopes has reported EBT over the past 4 years, most recently at -$63.1 million for Q4 2025.

  • On a quarterly basis, EBT fell 596.36% to -$63.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$159.6 million, a 393.81% decrease, with the full-year FY2025 number at -$159.6 million, down 393.81% from a year prior.
  • EBT reached -$63.1 million in Q4 2025 per ASPI's latest filing, down from -$12.8 million in the prior quarter.
  • The five-year high for EBT was -$827959.0 in Q2 2022, with the low at -$75.1 million in Q2 2025.
  • The 4-year median for EBT is -$5.6 million (2023), against an average of -$13.3 million.
  • The largest YoY upside for EBT was 21.67% in 2025 against a maximum downside of 746.47% in 2025.
  • Tracing ASPI's EBT over 4 years: stood at -$1.5 million in 2022, then plummeted by 186.53% to -$4.2 million in 2023, then plummeted by 117.13% to -$9.1 million in 2024, then crashed by 596.36% to -$63.1 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$63.1 million, -$12.8 million, and -$75.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.